Graft-Versus-Host Disease after Liver Transplantation.
- Author:
Hyeyoung KIM
1
;
Nam Joon YI
;
Kyung Suk SUH
;
Geon HONG
;
Young Min JEON
;
Kwang Woong LEE
;
Myung Hee PARK
;
Eung Ho CHO
;
Kuhn Uk LEE
Author Information
1. Department of Surgery, Seoul National University College of Medicine, Korea. kssuh@plaza.snu.ac.kr
- Publication Type:Original Article
- Keywords:
Graft-versus-host disease;
GVHD;
Liver transplantation;
Chimerism
- MeSH:
Carcinoma, Hepatocellular;
Chimerism;
Diarrhea;
Early Diagnosis;
Exanthema;
Fever;
Graft vs Host Disease;
Hepatitis B;
Humans;
Korea;
Leukocytes;
Liver;
Liver Cirrhosis;
Liver Transplantation;
Neutropenia;
Retrospective Studies;
Sepsis;
Tissue Donors
- From:Korean Journal of Hepato-Biliary-Pancreatic Surgery
2010;14(4):235-240
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Graft-Versus-Host Disease (GVHD) is a rare (0.1~2%) but severe complication after liver transplantation (LT). It is the most lethal complication after LT and there are currently no effective preventive or therapeutic measures available. Approximately 90 such cases have been reported in the literature, but only one case has been reported in Korea. METHODS: We performed a retrospective analysis of 767 patients who underwent LT (living donor:deceased donor=554:213) at Seoul National University Hospital, Korea from 1998 to 2009. Four patients (4/767, 0.52%) with histologically proven GVHD were found. The diagnosis of GVHD was made according to observing macrochimerism in the peripheral blood and the affected tissue biopsy. RESULTS: Four patients underwent LT due to Hepatitis B virus-related liver cirrhosis and two of these patients had coexisting hepatocellular carcinoma. Three patients received livers from deceased donors and one received a liver from a live donor. All their blood matching were identical. The first diagnosed case underwent human leukocyte antigen (HLA) typing only after LT and it showed complete one-way donor-recipient HLA matching. The onset of GVHD occurred between 10 days and 55 days after LT. All the patients developed high-grade fever, skin rash, neutropenia, diarrhea and the main signs and symptoms related to GVHD. All the patients died because of sepsis despite intensive treatment. CONCLUSION: GVHD after LT is an extremely rare and fatal complication and it is difficult to diagnose. Therefore, we should perform pre-transplant HLA matching and try to establish an early diagnosis for patients who are clinical suspicious of having GVHD. Further study in this area is needed and physicians need to be alert to detect this malady.
